EHMT2 and Alzheimer disease: Notably, 15 out of 38 of these AD/G9a-corregulated ‘modules’ were only dysregulated at the protein level without concomitant change in transcriptomic networks in the AD patient samples (Fig. 7E; highlighted in cyan).